project id: TCGA-BRCA; case submitter id: TCGA-A2-A0T7; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.0; rna integrity number: 9.2; age at index: 51; days to birth: -18756; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1958; age at diagnosis: 18756; ajcc pathologic m: M0; ajcc pathologic n: N0 (i+); ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 631.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 280; days to sample procurement: 0; initial weight: 990.0; portion submitter id: TCGA-A2-A0T7-01A-21; percent monocyte infiltration: 10.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;